Guangzhou Innogen Pharmaceutical Group Co LtdHKEX: 2591

Inside information - licence agreement with arcera life sciences ltd

· Issued by Guangzhou Innogen Pharmaceutical Group Co Ltd via HKEXnews

Filed with HKEX · Stock code 2591 · · 2 pages · English

Summary by 6ix AI

Guangzhou Innogen Pharmaceutical Group Co Ltd announced a licence agreement with Arcera Life Sciences Ltd, granting Arcera exclusive rights to develop and commercialize a pharmaceutical product in select regions. This move aims to leverage Arcera's commercial network to enhance the product's international expansion and value. The board believes this agreement is in the best interests of the company and its shareholders.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Guangzhou Innogen Pharmaceutical Group Co Ltd on 6ix

Earlier from Guangzhou Innogen Pharmaceutical

Later from Guangzhou Innogen Pharmaceutical

All Guangzhou Innogen Pharmaceutical news releases